EGFR and central nervous system cancer: Soluble proteins were purified by IMAC (Supplementary Fig. 15B) followed by SEC, concentrated and buffer exchanged into PBS (Fig. 4A) prior to testing in vitro activity in an EGFR-expressing glioma line, CT2A-EGFRviii.